Jonas, B., Abedi, M., Rosenberg, A., Esteghamat, N., Hoeg, R., Qi, L., Tam, E., Tuscano, J., Yaghmour, G. (2025). Ibrutinib plus blinatumomab in Relapsed/Refractory B-cell acute lymphoblastic leukemia: Results of A phase 2 study. Blood. https://doi.org/10.1182/blood-2025-3356